Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2020 Oct 22;112(2):387–394. doi: 10.1016/j.athoracsur.2020.08.040

Table 2:

Clinical outcomes in recipients

Variable PE- (N=479) PE+ (N=22) p
Double lung transplant 468 (97.7) 21 (95.5) 0.42
Complication
 Pulmonary embolism 7 (1.5) 0 (0) 1
 Pulmonary ventilation ≥ 48h 130 (27.1) 5 (22.7) 0.65
 Atrial arrhythmia 177 (37.0) 10 (45.5) 0.42
 Ventricular arrhythmia 8 (1.7) 0 (0) 1
 Myocardial infarction 2 (0.4) 0 (0) 1
 Deep vein thrombosis 48 (10.0) 1 (4.5) 0.71
 Neurological complication 5 (1.0) 0 (0) 1
 Renal failure 5 (1.0) 2 (9.1) 0.03
ACR 120 (25.1) 10 (45.5) 0.03
PGD grade ≧2 231 (48.2) 7 (31.8) 0.13
Length of hospital stay (days) 23.8±21.8 25.7±26.2 0.97
30-day/hospital mortality 14 (2.9) 1 (4.6) 0.50

Clinical outcomes in recipients receiving lungs with and without incidentally discovered pulmonary embolism (PE). Values are presented as n (%) or mean ± standard error of the mean. P values ≤ 0.05 are denoted in bold. The denominator for the percentages is the sum of patients across all categories in the PE+ or PE− group, respectively, excluding missing values. ACR, Acute cellular rejection; PE, pulmonary embolism; PGD, primary graft dysfunction.